News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
|
Followers
|
5
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
87
|
|
Created
|
08/12/04
|
Type
|
Free
|
| Moderators | |||
TIE Technologies Inc. (TIET - PINK) is a next generation communications company focused on developing, marketing, and selling products designed to improve connectivity and productivity. The company is focused on wireless communications, telecom services, security, and information management software solutions.
See http;//www.tietechnologies.net for more information
http://www.mdmgroupinc.com/biodefense.php
Biodefense Division
The major focus of Biodefense Division. (BDD) is the development of vaccines, drugs, diagnostics, and decontaminants for more effective prevention and control of bioterrorism threats. The vaccine developments include a candidate for smallpox virus, an agent that is as the top of the bio-warfare bio-terrorism threat list. A vaccine targeting influenza, in particular the H5N1 virus and variants is also being investigated. The final vaccine under development is a filovirus (Marburg) vaccine. All of these vaccines utilized novel technology, are completely synthetic, and are expected to be safe in all populations. A novel treatment for influenza is being evaluated and will soon be announced. BDD is working to provide a novel, rapid, oral diagnostic for H5N1 influenza. Finally, the BDD is looking into a novel method of decontamination using Russian technology.
BDD is working closely with a number of global partners including leading US and overseas universities as well as major government research groups such as Health Canada and the Russian Influenza Institute. Additional project development support will be gained via the ISTC (International Science and Technology Center) and BIOMAC (Biotechnological Consortium for Medicine and Agriculture) in Russia. The MDM Biodefense Division now has the capability to leverage western technologies and needs by directly working with a very established and accomplished scientific base including numerous Russian institutes and organizations.
The ISTC program is a part of a US Department of State program whose objective is to support nonproliferation in the area of nuclear, biological and chemical Weapons of Mass Destruction.
The BIOMAC Consortium was formed in 2001 within the framework of the Agreement between four ministries of the Russian Federation: Ministries of Industry, Science and Technology, Ministry of Health, Ministry of Agriculture, and the Ministry of Education. Since inception, BIOMAC has been expanded to include the Russian Academies of Sciences, of Medical Sciences, and of Agricultural Sciences.
Dr Edward L. Stephen, a specialist in bioterrorism and biodefense, heads the Biodefense Division of MDM Group, Inc. He is also a Harrington Group Advisory Board Member, and spearheads certain projects under development for the Harrington Group and its subsidiary Sun Biomedical.
His initial working assignment was at Ft. Detrick where, in the Special Operations Division, he played key roles in bioterrorism defense including assessment of vulnerability of limited targets such as the New York subway system and the Pentagon. Further, he was involved in the R&D of a range of weapons and helped to test and evaluate various kinds of drugs, chemicals, and toxins as they might relate to capture or restraint.
Most recently and for the past five (5) years, Dr. Stephen has been a Senior Project Manager at the International Science and Technology Center (ISTC; www.istc.ru). In this role, he was evaluating the scientific experience and expertise of scientists and support personnel involved in the R&D of biological weapons of mass destruction (BioWMD). He has reviewed the credentials and publications of scientists and support personnel of literally hundreds of individuals as the initial step of integrating this experience and expertise into collaborative bio-defense research projects between the governments of Russia and the US.
We expect to see some very exciting and sought after technologies emerge from this MDM Group subsidiary in 2006.
placed here 01/02/08
------------------------------------------------------------
Partners and Strategic Relationships
MDM Group and its subsidiary companies have partnered with or formed strategic alliances with the following world class companies and research institutions:
The Aerospace Corporation (http://www.aero.org)
The Aerospace Corporation is a private, nonprofit corporation that provide research, development, and advisory services. Although it is not a manufacturer, many of our 2000 scientists and engineers have developed one-of-a-kind prototypes and patented technologies used by government and commercial customers. Aerospace operates a Federally Funded Research and Development Center (FFRDC) for the Department of Defense (DOD).
The Engineering and Technology Group provides engineering and scientific expertise to other organizations, performs independent assessments of the technical status of acquisition programs, and assists in the introduction of new technology. The technical staff conducts applied research by developing and applying advanced models, simulations and analytic tools.
Chief Security Officers, LLC (http://www.chiefsecurityofficers.com)
CSO is a leading provider of audit, forensic, security, and compliance services. CSO's staff are the most technically talented and highly trained in the industry. The versatility and expertise of their staff and the company’s global reach has enabled CSO to develop a wide range of regulatory compliance, audit, and security awareness training programs.
EDS (http://www.eds.com)
EDS provides a broad portfolio of business and technology solutions to help its clients worldwide improve their business performance. Our core portfolio comprises information-technology, applications and business process services, as well as information-technology transformation services.
The Girvan Institute of Technology (http://www.girvan.org)
The Girvan Institute of Technology (GIRVAN) works to foster and facilitate the creation and growth of high-technology businesses. The institute was established in 2002 and is a California non-profit, public-benefit corporation, tax-exempt under federal and state regulations. Girvan headquarters is located in the heart of Silicon Valley. Harrington Group USA Inc. offices are based at the Girvan Institute facility.
Girvan is a platform for new hi-tech venture development inside the NASA Research Park (NRP) that acts as a catalyst for enabling technology commercialization and collaboration between NASA, other federal agencies, and the private sector. Through its Technology Showcase, GIRVAN assists private-sector companies in leveraging NASA and other federal agency technologies through these cooperative projects, influencing the contributions to intellectual property, materials, equipment, manpower, and other resources.
Sun Microsystems (http://www.sun.com)
Incorporated in 1982, Sun has had a history marked by great ideas, break-through thinking, and market shattering achievements.
Trusted Systems Library (http://www.trustedsyslabs.com)
Originally founded as a computer security product development team at a major U.S. aerospace corporation, Trusted Systems Laboratories combines technological know-how and innovation to provide security products and services for the e-commerce marketplace. This team has designed, analyzed, and developed trusted systems as well as security products and high assurance systems for commercial and government customers.
------------------------------------------------------------
these above will be updates as MDDM gives them. 01/02/08
------------------------------------------------------------
Investor Relations> MDM Stock Info
Stock Info
MDM GROUP SHARE AND TRADING INFORMATION:
Symbol: MDDM
Exchange: OTC Pink Sheets
Industry: Security/Technology
Shares Outstanding: Approx. 38 million
Shares in Float: Approx. 5 million
Shareholders: Approx. 100
HARRINGTON GROUP LIMITED SHARE AND TRADING INFORMATION:
Symbol: HGR
Symbol (Options): HGRO
USA equivalent symbol: HGRLF
Exchange: Australian Stock Exchange
Industry: Security/Technology
Shares Outstanding: 140.3m
Shares in Float: 68.7
Listed AUD$0.25 Options: 11.3m
Shareholders: Approx. 750
INVESTOR RELATIONS AGORACOM
TRANSFER AGENT
Signature Stock Transfer, Inc.
2301 Ohio Drive, Suite 100
Plano, Texas 75093
-----------------------------------------------------------
these above will be updates as MDDM gives them. 01/02/08
----------------------------------------------------------
About MDM> Management
Management
http://www.mdmgroupinc.com/aboutmdm/management.php
Peter Boonen - Executive Chairman and CEO, MDM Group
Mr. Peter Boonen is the founder of the Company. Mr. Boonen is responsible for the overall corporate development focus and strategy, and for the company's relationship development. He has over 30 years of extensive business experience in the property, investment banking and equity markets in Australia, the US, Canada and the UK. Mr Boonen is Managing Director of Harrington Group Limited.
Chris Nichols - Director, Vice President, MDM Group and IT Data Security
Mr. Chris Nichols is responsible for the Company's research, technology development, and product strategy responding to focused high-assurance communications and security infrastructure and vertical industry business- driven needs. Mr. Nichols is also President/CEO of TIE Technologies, Inc., an MDM Group company focused on developing advanced wired and wireless communications and information management solutions. At TIE Mr. Nichols has been responsible for developing and executing the company's business plan. Mr. Nichols has had vast industry experience in the electronic medium. He has extensive knowledge of computer operating systems, security technologies, trusted systems, broadband connectivity, broadband switching, and broadcast quality digital video.
Barry Evans - Non Executive Director
Mr. Barry Evans is a non-executive director of the Company and provides to the Board all the benefits of a distinguished business career. He was a founding partner of CARE Systems Corporation, a workers compensation software and administration group having revenues of approximately $100 million per annum when control of that business was sold. Barry was previously the General Manager for Mattingly Advertising and was a General Manager and director for group companies of Australian Consolidated Industries, one of Australia's major companies with international operations.
------------------------------------------------------------
these above will be updates as MDDM gives them. 01/02/08
------------------------------------------------------------
http://www.mdmgroupinc.com/sitemap.htm
------------------------------------------------------------
About MDM> Advisory Board
Advisory Board
http://www.mdmgroupinc.com/aboutmdm/board.php
MDM Group Inc. through arrangement with its 45% subsidiary Harrington Group Limited has access to the consulting advice of the Harrington Group Advisory Board. The Advisory Board charter has the Advisory Board meeting approximately six monthly to provide scientific advice and guidance to the Company to assist with its strategic decision making. The Advisors also work closely with each other in between the Advisory Board meetings and some provide additional consulting services to the Company.
Board of Advisors
Colonel John B. Alexander, Ph.D. (US Army Ret) - Chairman
Colonel Alexander is recognized and acknowledged as one of the world's leading authorities on non-lethal weapons and is credited with developing the modern concept of non-lethal defense. He currently serves as a consultant to the US Joint Special Operations University and is a member of the National Research Council Committee for Assessment of Non-Lethal Weapons Science and Technology in the US.
Colonel Alexander continues to consult to the US government and provide guidance in military situations globally in which role he recently served as a mentor to the senior leadership of the Afghan MOD in Kabul. He previously headed the Los Alamos Laboratory program on non-lethal weapons. He has served as the US representative on four international studies conducted by NATO and has chaired most of the major conferences on non-lethal weapons over the past decade.
His books include "Future War" (foreword by Tom Clancy) which is "the bible for those seeking answers to the role of non-lethal weapons in modern warfare" according to General E.C. Meyers, former Chief of Staff, US Army. Numerous articles by Colonel Alexander have been published and he has also appeared on many television programs including: Dateline, Fox News, Larry King, CNN in the US as well as programs in Australia, Denmark, France, Germany, Italy, Switzerland, Netherlands, the UK, and Japan.
As a member of the Council on Foreign Relations non-lethal warfare study, he was instrumental in the report that is credited with causing the Department of Defense to create a formal Non-Lethal Weapons Policy in July 1996. He has also conducted numerous non-lethal warfare briefings to the highest levels of government including the White House Staff, National Security Council, Members of Congress, Director of Central Intelligence, and senior Defense officials.
Christopher C. Green, MD, PhD, FAAFS
Dr Green is in the practice of forensic medicine (American Academy of Forensic Sciences) and neuroimaging (Detroit Medical Center/Harper University Hospital/Wayne School of Medicine). His work clinically relates to his expertise as a neurophysiologist with a specialty in electrophysiology. A special research interest involves the way cognition in "making decisions under stress" are modulated by brain systems and neuromuscular control. He is both a faculty member at the Medical School and Fellow in Diagnostic Radiology, and Executive Director for Emergent Technologies.
Dr Green serves on numerous Department of Defense, Intelligence and National Academy of Sciences Commissions. He Chairs the Science Board for the Undersecretary of the Army for Operations Research and has served as Chair of the Board on Army Science and Technology. He holds the National Intelligence Medal for investigations in forensic intelligence and served as an Officer and continues as a consultant with the Central Intelligence Agency.
Edward L. Stephen, DVM
Dr Edward L. Stephen is a specialist in bioterrorism and biodefense and in this field also heads up the biodefense division of MDM Group, Inc.
His initial working assignment was at Ft. Detrick where, in the Special Operations Division, he played key roles in bioterrorism defense including assessment of vulnerability of limited targets such as the New York subway system and the Pentagon. Further, he was involved in the R&D of a range of weapons and helped to test and evaluate various kinds of drugs, chemicals, and toxins as they might relate to capture or restraint.
Most recently and for the past five (5) years, Dr. Stephen has been a Senior Project Manager at the International Science and Technology Center (ISTC; www.istc.ru). In this role, he has been evaluating the scientific experience and expertise of scientists and support personnel involved in the R&D of biological weapons of mass destruction (BioWMD). He has reviewed the credentials and publications of scientists and support personnel of literally thousands of individuals as the initial step of integrating this experience and expertise into collaborative bio-defense research projects between the governments of Russia and the US. During future visits to Russia, he will be discussing the current and future R&D needs of the Harrington Group with various organisations.
Allen I Bain, PhD
Dr Bain is a pharmacologist focused on new drug development including, treatments for disorders of the brain, heart and other electrically active tissue. As a co-founder, officer, or director of several companies spanning nearly two decades, Dr Bain has participated in leadership roles in both the business and the science of drug discovery. Most notably, Dr. Bain co-founded Cardiome Pharma (NASDAQ: CRME), whose flagship ion channel modulating drug to treat cardiac arrhythmias is in Phase 3 clinical trials in the U.S., supported by a large pharmaceutical company. Until recently, Dr Bain was an honorary lecturer at the Department of Pharmacology and Therapeutics at the University of British Columbia, where he was awarded his doctorate in pharmacology in 1994 for his work in neuroscience.
------------------------------------------------------------
these above will be updates as MDDM gives them. 01/02/08
------------------------------------------------------------
one year chart:
AI
